About the journal
CNS Drugs is a journal published by Adis, Springer Healthcare in New Zealand. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Adis, Springer Healthcare
- ISSN
- 1172-7047 · 1179-1934
- Country
- New Zealand
- Access
- Not open access / not declared
- Declared publication charge
- 4,390 EUR
- Declared peer-review model
- peer_review
- Official website
- https://www.springer.com/journal/40263
Index listings
- MEDLINE · 2001-01-01
- PUBMED · 2011-06-01
- Indexing
- MEDLINE · PUBMED
- APC
- 4,390 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 137 days received→accepted — computed from PubMed (n=89)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
2946
Last recorded publication year
2026
h-index
162
i10-index
2091
From OpenAlex open data (CC0).
Editorial & policy6
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 93%
- ORCID iDs in current deposits
- 89%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Central Nervous System drugs
- Source type
- journal
- NLM unique ID (PubMed)
- 9431220
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Schizophrenia research and treatment
- Schizophrenia research and treatment
- Epilepsy research and treatment
- Epilepsy research and treatment
- Treatment of Major Depression
- Treatment of Major Depression
- Pharmacological Effects and Toxicity Studies
- Pharmacological Effects and Toxicity Studies
Show all subjects (50)
- Bipolar Disorder and Treatment
- Bipolar Disorder and Treatment
- Neurotransmitter Receptor Influence on Behavior
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
- Neuroscience and Neuropharmacology Research
- Attention Deficit Hyperactivity Disorder
- Parkinson's Disease Mechanisms and Treatments
- Attention Deficit Hyperactivity Disorder
- Parkinson's Disease Mechanisms and Treatments
- Multiple Sclerosis Research Studies
- Multiple Sclerosis Research Studies
- Electroconvulsive Therapy Studies
- Electroconvulsive Therapy Studies
- Migraine and Headache Studies
- Migraine and Headache Studies
- Neurological disorders and treatments
- Neurological disorders and treatments
- Tryptophan and brain disorders
- Tryptophan and brain disorders
- Sleep and Wakefulness Research
- Sleep and Wakefulness Research
- Sleep and related disorders
- Sleep and related disorders
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Obsessive-Compulsive Spectrum Disorders
- Obsessive-Compulsive Spectrum Disorders
- Acute Ischemic Stroke Management
- Acute Ischemic Stroke Management
- Cholinesterase and Neurodegenerative Diseases
- Cholinesterase and Neurodegenerative Diseases
- Alzheimer's disease research and treatments
- Alzheimer's disease research and treatments
- Pain Mechanisms and Treatments
- Pain Mechanisms and Treatments
- Peripheral Neuropathies and Disorders
- Peripheral Neuropathies and Disorders
- Botulinum Toxin and Related Neurological Disorders
- Parkinson's Disease and Spinal Disorders
- Parkinson's Disease and Spinal Disorders
- Botulinum Toxin and Related Neurological Disorders
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ